Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-37,900
Closed -$2.16M 4344
2024
Q4
$2.16M Hold
37,900
﹤0.01% 2663
2024
Q3
$2.23M Sell
37,900
-30,000
-44% -$1.64M ﹤0.01% 2633
2024
Q2
$3.66M Hold
67,900
﹤0.01% 2096
2024
Q1
$3.92M Buy
67,900
+15,400
+29% +$795K ﹤0.01% 2074
2023
Q4
$2.52M Buy
+52,500
New +$2.5M ﹤0.01% 2491
2021
Q1
Sell
-26,400
Closed -$1.02M 4116
2020
Q4
$1.02M Hold
26,400
﹤0.01% 3008
2020
Q3
$761K Hold
26,400
﹤0.01% 3020
2020
Q2
$707K Sell
26,400
-44,550
-63% -$1.16M ﹤0.01% 3147
2020
Q1
$1.67M Sell
70,950
-26,928
-28% -$740K ﹤0.01% 2325
2019
Q4
$2.89M Hold
97,878
﹤0.01% 2176
2019
Q3
$2.74M Sell
97,878
-9,900
-9% -$286K ﹤0.01% 2125
2019
Q2
$3.19M Buy
+107,778
New +$2.9M ﹤0.01% 1921

Other funds holding CTVA

David Shaw's CTVA Position: Q2 2026 in Review

David Shaw reduced its Corteva (CTVA) stake by 56% in Q2 2026, selling an estimated $12.8M and leaving 125,655 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #1762.

David Shaw first reported a position in CTVA in Q2 2019 and has held it in 27 quarters since. The position peaked at $121M in Q2 2019. 1,485 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • David Shaw held 125,655 shares of Corteva worth $10.6M as of Q2 2026.
  • David Shaw sold 159,551 Corteva shares in Q2 2026, an estimated $12.8M.
  • Corteva made up 0.01% of David Shaw's portfolio in Q2 2026, its #1762 holding.
  • David Shaw first reported a position in Corteva in Q2 2019 and has held it in 27 quarters since.
  • David Shaw's Corteva position peaked at $121M in Q2 2019.
  • 1,485 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.